spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Northway Biotechpharma Celebrates 15 Years of Growth and Success

Northway Biotechpharma


History of Rapid Growth
Founded in 2004 as a CDMO providing support for branded biologics and biosimilars, Northway Biotechpharma –– then just Biotechpharma –– began operating in rented space for product development and small-scale GMP manufacturing activities. During the past 15 years, the company has become a full-service CDMO with capabilities in cell line development, process development and optimization and mid-volume GMP manufacturing of biologic drug substances and drug products –– both branded biopharmaceuticals and biosimilars.

Strong Customer Focus
Throughout its first 15 years, Northway Biotechpharma has focused on providing its customers with the highest level of quality and service. Today, the track record of performance and high level of trust that the CDMO has established with its customers result in frequent recommendations and an increasing number of customers. Northway Biotechpharma is deeply invested in providing high quality, world-class CDMO services and long-term partnerships based on its blend of experience and openly collaborative project teams.

Ongoing Commitment to Reinvestment
The commitment to Northway Biotechpharma’s customers is also reflected in the company’s ongoing willingness to reinvest and enhance its services and capabilities. Recent management changes, new branding and new capacity are enabling Northway Biotechpharma to further advance its mission of becoming a single-source CDMO able to support its worldwide customers with a full range of development and manufacturing services from the clinic to the market.

Exciting Future Ahead
“The entire history of Northway Biotechpharma is important and has made an impact on what we are today and helped establish the values we live by: leadership, openness to change, creativity, strategic discipline and excellent execution are the keys to our success,” commented Dr. Vladas Bumelis, founder of Biotechpharma and Chairman of the company’s Board of Directors and Advisory Board.

Giedrius Žunda, CEO of Northway Biotechpharma, added “I see a great opportunity to leverage the company’s vertically integrated business model and to lead its talented employees to deliver increased value for shareholders. I am excited to lead this organization to its next stage of evolution.” About Northway Biotechpharma Northway Biotechpharma is a contract development and manufacturing organization (CDMO) supporting worldwide customers. Its highly experienced biochemistry, biology and bioprocess engineering staff can deliver projects at any stage, from cell line construction and process development to cGMP production of biopharmaceutical products. High-quality performance and on-time delivery are guaranteed by a team of highly qualified and experienced researchers, engineers, technologists and management professionals.
email bd@northwaybiotech.com
web https://www.northwaybiotech.com/
email Northway Biotechpharma Mokslininku str. 4 LT-08412 Vilnius, Lithuania
 
Print this page
Send to a friend
   
spacer
News and Press Releases

PCI Pharma Services Announces Further Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility

Philadelphia, PA – June 4, 2019 PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has announced the growth of its West Coast Clinical operations with expansion into its third facility in San Diego.
More info >>


White Papers

Choosing the Right CMO for HPAPI Manufacturing

AMRI

Over the past few years a steady stream of contract manufacturing organizations (CMO) have added high potency active pharmaceutical ingredient (HPAPI) production capacity. The expansions give biopharma executives charged with selecting HPAPI production partners an unprecedented number of options, but all this choice creates a problem — which CMO should you pick when each is touting similar technical capabilities?
More info >>

Industry Events

FlyPharma Europe

22-23 October 2019, Copenhagen, Denmark

The FlyPharma Conference Europe 2019 is aimed at forward-thinking individuals and businesses that are ready to uncover the potential in their pharma supply chain. The event offers an interactive platform to discuss current and future challenges within pharma and cargo, with topics including market trends, cold chain innovations, latest regulatory demands, security technology, and how to encourage collaboration between supply chain players. There will be plenty of networking opportunities, including a complimentary evening networking event, where delegates can meet and catch up with senior and executive pharma and cargo professionals – gaining strong, new industry contacts and building on existing ones.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement